Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma (Q36700470)
Jump to navigation
Jump to search
scientific article published on 11 January 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma |
scientific article published on 11 January 2016 |
Statements
1 reference
Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma (English)
1 reference
Andreas Viardot
1 reference
Marie-Elisabeth Goebeler
1 reference
Georg Hess
1 reference
Svenja Neumann
1 reference
Nicole Adrian
1 reference
Florian Zettl
1 reference
Martin Libicher
1 reference
Cyrus Sayehli
1 reference
Julia Stieglmaier
1 reference
Alicia Zhang
1 reference
Dirk Nagorsen
1 reference
Ralf C Bargou
1 reference
11 January 2016
1 reference
1 reference
1410-1416
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference